Panagora Asset Management’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-20,724
Closed -$234K 1481
2022
Q2
$234K Sell
20,724
-5,701
-22% -$68.3K ﹤0.01% 1367
2022
Q1
$429K Buy
26,425
+12,812
+94% +$328K ﹤0.01% 1267
2021
Q4
$645K Buy
13,613
+3,981
+41% +$239K ﹤0.01% 1109
2021
Q3
$698K Buy
9,632
+4,337
+82% +$314K ﹤0.01% 1147
2021
Q2
$445K Buy
+5,295
New +$349K ﹤0.01% 1369

Other funds holding NBP

Panagora Asset Management's NBP Position: Q3 2022 in Review

Panagora Asset Management sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q3 2022, closing a stake of 20,724 shares — an estimated $234K sold.

Panagora Asset Management first reported a position in NBP in Q2 2021 and held it in 5 quarters. The position peaked at $698K in Q3 2021. 75 funds tracked by Wall St. Rank hold NBP as of Q3 2022.

  • Panagora Asset Management reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q3 2022 after selling out during the quarter.
  • Panagora Asset Management sold 20,724 NovaBridge Biosciences American Depositary Shares shares in Q3 2022, an estimated $234K.
  • Panagora Asset Management first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2021 and held it in 5 quarters.
  • Panagora Asset Management's NovaBridge Biosciences American Depositary Shares position peaked at $698K in Q3 2021.
  • 75 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q3 2022.

Based on Panagora Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.